Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.19.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2018
Dec. 31, 2017
Current assets    
Cash and cash equivalents $ 18,050 $ 6,939
Short-term investments 3,043  
Accounts receivable 5
Inventory 23 6
Prepaid expenses and other current assets 930 739
Deferred financing fees 602
Total current assets 22,051 8,286
Fixed assets, net 846 783
Other non-current assets 57 99
Total assets 22,954 9,168
Current liabilities    
Accounts payable and accrued expenses 2,140 1,733
Other current liabilities 253 250
Total current liabilities 2,393 1,983
Contingent royalty obligation 1,953 1,662
Other non-current liabilities 91
Total liabilities 4,437 3,645
Shareholders' equity    
Preferred stock
Common stock $0.0001 par value; 50,000,000 shares authorized; 21,440,148 and 10,493,233 shares issued and outstanding as of December 31, 2018 and December 31, 2017, respectively 2 1
Additional paid-in capital 79,893 44,643
Accumulated deficit (61,378) (39,121)
Total shareholders' equity 18,517 5,523
Total liabilities and shareholders' equity 22,954 9,168
Preferred Series A stock [Member]    
Shareholders' equity    
Preferred stock